Hypnosis for Transesophageal Echocardiography
I-SLEPT
Utility of Hypnosis for Transesophageal Echocardiography
2 other identifiers
interventional
101
1 country
1
Brief Summary
The purpose of this study is to determine the additive value of hypnosis to improve patient comfort during transesophageal echocardiography (TEE).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2010
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 29, 2010
CompletedFirst Posted
Study publicly available on registry
March 30, 2010
CompletedStudy Start
First participant enrolled
May 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2011
CompletedDecember 19, 2013
March 1, 2010
6 months
March 29, 2010
December 18, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Level of patient comfort
Visual Analogic Scale
at Day 0
Secondary Outcomes (3)
Rate of procedure failure or non-diagnostic study
at Day 0
Duration of the procedure
at Day 0
Quality of the procedure as assessed by the operator
at Day 0
Study Arms (2)
Conventional procedure
ACTIVE COMPARATORLocal anaesthesia (Lidocaïne)
Conventional procedure + Hypnosis
EXPERIMENTALLocal anaesthesia (Lidocaïne) and Hypnosis
Interventions
Local anaesthesia (Lidocaïne) + Hypnosis (20 minutes)
Eligibility Criteria
You may qualify if:
- Patient with indication for a Transesophageal Echo (TEE)
- Patient competent to provide written informed consent
You may not qualify if:
- Patient not subscribed to French Social Security System
- Patient non-French speaking
- Age \< 18 years
- Follow-up not possible
- patient declared non competent to give informed consent for the study
- History of severe personality disorder
- Patient with a psychiatric treatment started 30 days before the exam
- Patient pregnant or breast-feeding
- Emergency TEE
- Other indication for general anesthesia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital LARIBOISIERE Cardiologie - Laboratoire d'Échocardiographie Doppler
Paris, 75010, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
François TOURNOUX, MD
Assistance Publique - Hôpitaux de Paris
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 29, 2010
First Posted
March 30, 2010
Study Start
May 1, 2010
Primary Completion
November 1, 2010
Study Completion
February 1, 2011
Last Updated
December 19, 2013
Record last verified: 2010-03